--- a
+++ b/clusters/9knumclustersv2/clust_1172.txt
@@ -0,0 +1,68 @@
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate end-organ function
+Adequate hematologic and end organ function based on laboratory results obtained within  days prior to initiation of study treatment;
+Adequate hematologic and end-organ function, defined by laboratory test results, obtained within  days before initiation of study treatment
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function Cancer-Related Inclusion Criteria:
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate haematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function obtained within  weeks prior to first dose of study drug
+Adequate End organ function
+Adequate hematologic and end organ function
+Adequate end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function.
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function test results
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function, confirmed by laboratory results obtained within  days prior to initiation of study drug
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function within  days prior to treatment initiation
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function, defined by the following laboratory results obtained within  days prior to the first study treatment (Cycle , Day ):
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function Cohort -Specific Inclusion Criteria
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate end organ function as defined by:
+Adequate hematologic and end organ function
+End-organ function not appropriate for transplantation
+Adequate hematologic and end organ function, defined by the following laboratory results obtained within  days prior to the first study treatment (Cycle , Day )
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end organ function
+Adequate hematologic and end organ function
+Adequate hematologic, cardiac, and end-organ function
+Adequate hematologic and end-organ function
+Adequate hematologic and end-organ function
+Adequate end organ function as defined by:
+Adequate hematologic and end organ function
+Adequate hematologic and end-organ function